Trial intelligence / Profile preview

Fospropofol disodium versus propofol for hemodynamic effects during supratentorial tumor resection

ChiCTR2300074155Phase 4Not yet recruiting

Sponsor
Xiangya Hospital, Central South University
Start
Aug 2023
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in brain neoplasm comparing Fospropofol group with Propofol group (2 arms). Primary endpoint: Blood pressure. Planned start Aug 2023; status: not yet recruiting.

02

Drugs

fospropofol disodiumpropofol
03

Conditions

brain neoplasm

Beyond the preview

Go deeper on ChiCTR2300074155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300074155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call